Literature DB >> 26687282

A network analysis of the Chinese medicine Lianhua-Qingwen formula to identify its main effective components.

Chun-Hua Wang1, Yi Zhong2, Yan Zhang1, Jin-Ping Liu1, Yue-Fei Wang1, Wei-Na Jia1, Guo-Cai Wang3, Zheng Li1, Yan Zhu1, Xiu-Mei Gao1.   

Abstract

Chinese medicine is known to treat complex diseases with multiple components and multiple targets. However, the main effective components and their related key targets and functions remain to be identified. Herein, a network analysis method was developed to identify the main effective components and key targets of a Chinese medicine, Lianhua-Qingwen Formula (LQF). The LQF is commonly used for the prevention and treatment of viral influenza in China. It is composed of 11 herbs, gypsum and menthol with 61 compounds being identified in our previous work. In this paper, these 61 candidate compounds were used to find their related targets and construct the predicted-target (PT) network. An influenza-related protein-protein interaction (PPI) network was constructed and integrated with the PT network. Then the compound-effective target (CET) network and compound-ineffective target network (CIT) were extracted, respectively. A novel approach was developed to identify effective components by comparing CET and CIT networks. As a result, 15 main effective components were identified along with 61 corresponding targets. 7 of these main effective components were further experimentally validated to have antivirus efficacy in vitro. The main effective component-target (MECT) network was further constructed with main effective components and their key targets. Gene Ontology (GO) analysis of the MECT network predicted key functions such as NO production being modulated by the LQF. Interestingly, five effective components were experimentally tested and exhibited inhibitory effects on NO production in the LPS induced RAW 264.7 cell. In summary, we have developed a novel approach to identify the main effective components in a Chinese medicine LQF and experimentally validated some of the predictions.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26687282     DOI: 10.1039/c5mb00448a

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  25 in total

Review 1.  Role of natural products towards the SARS-CoV-2: A critical review.

Authors:  Kannan Raman; Kalirajan Rajagopal; Fahadul Islam; Manish Dhawan; Saikat Mitra; Baliwada Aparna; Potlapati Varakumar; Gowramma Byran; Om Prakash Choudhary; Talha Bin Emran
Journal:  Ann Med Surg (Lond)       Date:  2022-07-02

Review 2.  Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.

Authors:  Yu-Qiong He; Can-Can Zhou; Lu-Yao Yu; Liang Wang; Jiu-Ling Deng; Yu-Long Tao; Feng Zhang; Wan-Sheng Chen
Journal:  Pharmacol Res       Date:  2020-09-29       Impact factor: 7.658

3.  Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen).

Authors:  Shuaishuai Chen; Xiaojuan Yang; Ziying Wei; Yanru Zhang; Ying Huang; Zhuo Shi; Ziteng Zhang; Jiabo Wang; Haizhu Zhang; Jianli Ma; Xiaohe Xiao; Ming Niu
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

4.  Combining Chemical Profiling and Network Analysis to Investigate the Pharmacology of Complex Prescriptions in Traditional Chinese Medicine.

Authors:  Tongchuan Suo; Jinping Liu; Xi Chen; Hua Yu; Tenglong Wang; Congcong Li; Yuefei Wang; Chunhua Wang; Zheng Li
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

Review 5.  Chinese Herbal Medicine Meets Biological Networks of Complex Diseases: A Computational Perspective.

Authors:  Shuo Gu; Jianfeng Pei
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-11       Impact factor: 2.629

6.  Establishment and validation of a drug-target microarray for SARS-CoV-2.

Authors:  Peng Chen; Zehua Zeng; Hongwu Du
Journal:  Biochem Biophys Res Commun       Date:  2020-07-21       Impact factor: 3.575

7.  Efficacy and safety of Lianhua Qingwen in the treatment of patients with moderate COVID-19 infection: A protocol for systematic review and meta analysis.

Authors:  Nanyang Liu; Tingting Zhang; Lina Ma; Huican Wang; Yu Cao; Yang Yang; Hui Pei; Hao Li
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.889

8.  Traditional Chinese medicine Lianhua Qingwen treating corona virus disease 2019(COVID-19): Meta-analysis of randomized controlled trials.

Authors:  Mengjie Zeng; Linjun Li; Zhiquan Wu
Journal:  PLoS One       Date:  2020-09-11       Impact factor: 3.240

9.  Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis.

Authors:  Guohua Yu; Wubin Wang; Xu Wang; Meng Xu; Lili Zhang; Lei Ding; Rui Guo; Yuanyuan Shi
Journal:  BMC Complement Altern Med       Date:  2018-11-01       Impact factor: 3.659

10.  The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis.

Authors:  Qiongshuai Zhang; Fang Cao; Guangcheng Ji; Xiaohong Xu; Yihan Sun; Jiannan Li; Xun Qi; Shaoqian Sun; Yufeng Wang; Bailin Song
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.